1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pharmacogenomics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Technology
6.1 Polymerase Chain Reaction
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Microarray
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 DNA Sequencing
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Mass Spectrometry
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Electrophoresis
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Application
7.1 Oncology
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Infectious Diseases
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cardiovascular Diseases
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Neurological Diseases
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Psychiatry
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Pain Management
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Academic and Research Institutes
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AstraZeneca plc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bayer AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Becton Dickinson and Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Bio-Rad Laboratories Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.7 GlaxoSmithKline plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Illumina Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Johnson & Johnson
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Merck KGaA
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Myriad Genetics Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Qiagen N.V.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13 Thermo Fisher Scientific Inc
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: Pharmacogenomics Market: Major Drivers and Challenges
Figure 2: Global: Pharmacogenomics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Pharmacogenomics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Pharmacogenomics Market: Breakup by Technology (in %), 2024
Figure 5: Global: Pharmacogenomics Market: Breakup by Application (in %), 2024
Figure 6: Global: Pharmacogenomics Market: Breakup by End User (in %), 2024
Figure 7: Global: Pharmacogenomics Market: Breakup by Region (in %), 2024
Figure 8: Global: Pharmacogenomics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Pharmacogenomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Pharmacogenomics (Microarray) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Pharmacogenomics (Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Pharmacogenomics (DNA Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Pharmacogenomics (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Pharmacogenomics (Mass Spectrometry) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Pharmacogenomics (Mass Spectrometry) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Pharmacogenomics (Electrophoresis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Pharmacogenomics (Electrophoresis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Pharmacogenomics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Pharmacogenomics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Pharmacogenomics (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Pharmacogenomics (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Pharmacogenomics (Infectious Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Pharmacogenomics (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Pharmacogenomics (Cardiovascular Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Pharmacogenomics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Pharmacogenomics (Neurological Diseases) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Pharmacogenomics (Neurological Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Pharmacogenomics (Psychiatry) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Pharmacogenomics (Psychiatry) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Pharmacogenomics (Pain Management) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Pharmacogenomics (Pain Management) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Pharmacogenomics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Pharmacogenomics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Pharmacogenomics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Pharmacogenomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Pharmacogenomics (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Pharmacogenomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: North America: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: North America: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: United States: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: United States: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Canada: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Canada: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Asia-Pacific: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Asia-Pacific: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: China: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: China: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Japan: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Japan: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: India: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: India: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: South Korea: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: South Korea: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Australia: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Australia: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Indonesia: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Indonesia: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Others: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Others: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Europe: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Europe: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Germany: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Germany: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: France: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: France: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: United Kingdom: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: United Kingdom: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Italy: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Italy: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Spain: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Spain: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Russia: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Russia: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Others: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Others: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Latin America: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Latin America: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Brazil: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Brazil: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Mexico: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Mexico: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Others: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Others: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Middle East and Africa: Pharmacogenomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: Middle East and Africa: Pharmacogenomics Market: Breakup by Country (in %), 2024
Figure 86: Middle East and Africa: Pharmacogenomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Global: Pharmacogenomics Industry: SWOT Analysis
Figure 88: Global: Pharmacogenomics Industry: Value Chain Analysis
Figure 89: Global: Pharmacogenomics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Pharmacogenomics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Pharmacogenomics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 3: Global: Pharmacogenomics Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 4: Global: Pharmacogenomics Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 5: Global: Pharmacogenomics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Pharmacogenomics Market: Competitive Structure
Table 7: Global: Pharmacogenomics Market: Key Players